http://www.medicinenet.com/script/main/art.asp?li=MNI&articlekey=20958
|
|
|
![]() |
![]() |
![]() |
|
|
|
|
|
|
|
Allergy Nasal Drug for 2-Year-OldsA short article. For more, please visit the following MedicineNet.com areas:
Frederick Hecht, MD, FAAP, FACMG FDA OKs inhaled allergy drug for 2-year-olds Last Updated: 2002-07-19 13:02:46 -0400 NEW YORK (Reuters Health) - The US Food and Drug Administration (FDA) has approved the allergy drug Nasonex (mometasone furoate), made by Schering-Plough Corp., for use in children as young as 2 years old, the company reported Friday. In December 1999, the agency cleared the drug for patients aged 3 years and older. According to Schering-Plough, the approval makes Nasonex the only prescription nasal-inhaled corticosteroid approved for children that young. It was based on a study showing the drug's safety and tolerability in more than 50 children, the company said. Schering-Plough estimated that allergic rhinitis, or nasal inflammation, affects more than 6 million children each year. Copyright © 2002 Reuters Limited. All rights reserved.
Republication or redistribution of Reuters content, including by framing or
similar means, is expressly prohibited without the prior written consent of
Reuters. Reuters shall not be liable for any errors or delays in the
content, or for any actions taken in reliance thereon.
|
|
|
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||
![]() |
|
|
|
|
|
© 1996-2002
MedicineNet, Inc. All rights reserved.
Notices and Legal Disclaimer. Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider. Statements and information regarding dietary supplements have not been evaluated or approved by the Food and Drug Administration. Please consult your healthcare provider before beginning any course of supplementation or treatment. |
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.